• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Paratek Announces License Grant to Almirall SEYSARA® for Greater China Region

    GLOBENEWSWIRE

    Almirall LLC Announces Long-Term Safety Data For The Use Of Seysara

    PR NEWSWIRE

    Why Barnes & Noble, Paratek Pharmaceuticals, and Hortonworks Jumped Today

    Paratek enters commercial stage with 2 FDA antibiotics nods

    FIERCE PHARMA

    Green light for acne drug Seysara in the US

    PHARMA TIMES

    FDA Approves SEYSARA (Sarecycline) for Inflammatory Lesions of Acne Vulgaris

    Almirall acquires Allergan U.S. medical dermatology portfolio

    PR NEWSWIRE

    Almirall acquires Allergan`s US dermatology portfolio for $650 million

    PHARMA TIMES

    Paratek Announces FDA Advisory Committee Date for Omadacycline

    PRESS RELEASE

    Paratek Provides Update on Pipeline Progress

    PRESS RELEASE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.